ID: ALA3740483

Max Phase: Preclinical

Molecular Formula: C16H19BrF3N5O4

Molecular Weight: 368.24

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc(CCn2cc(C(=O)NCCN)nn2)cc1Br.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C14H18BrN5O2.C2HF3O2/c1-22-13-3-2-10(8-11(13)15)4-7-20-9-12(18-19-20)14(21)17-6-5-16;3-2(4,5)1(6)7/h2-3,8-9H,4-7,16H2,1H3,(H,17,21);(H,6,7)

Standard InChI Key:  FKEUYBRGMYSWQE-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 368.24

Molecular Weight (Monoisotopic): 367.0644

AlogP: 0.98

#Rotatable Bonds: 7

Polar Surface Area: 95.06

Molecular Species: BASE

HBA: 6

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.68

CX Basic pKa: 9.16

CX LogP: 1.31

CX LogD: -0.44

Aromatic Rings: 2

Heavy Atoms: 22

QED Weighted: 0.76

Np Likeness Score: -1.51

References

1. Andjouh S, Blache Y..  (2015)  Click-based synthesis of bromotyrosine alkaloid analogs as potential anti-biofilm leads for SAR studies.,  25  (24): [PMID:26564265] [10.1016/j.bmcl.2015.10.073]

Source

Source(1):

• Scientific Literature